Results 31 to 40 of about 31,072 (141)
, 2022 Selected clinical and laboratory parameters in patients with localized alopecia areata and patients with alopecia totalis / universalis.
Adriana Rakowska (8148795) +7 more
core +1 more source
Hydroxychloroquine treatment for Alopecia Universalis: Report of six cases
, 2021 Recent reports indicate that hydroxychloroquine is a potential new treatment option for alopecia universalis; thus, we aimed to report on the safety and efficacy of hydroxychloroquine in 6 patients with refractory alopecia universalis that were treated ...
Neslihan Akdogan +3 more
core +1 more source
Przegląd Dermatologiczny, 2023 The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska +8 more
doaj +1 more source
Alopecia areata universalis elicited during treatment with adalimumab [PDF]
, 2008 Adalimumab is a fully humanized recombinant anti-tumour-necrosis-factor (TNF-alpha) monoclonal antibody which has been approved for rheumatoid arthritis, active ankylosing spondylitis, psoriatic arthritis and Crohn's disease. We report a case of alopecia
Braathen, Lasse R +4 more
core +2 more sources
Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth.
, 2023 Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells.
Schwartzberg, Lauren, DO, Spizuoco, Amy
core +1 more source
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Alopecia Universalis after Treatment with Simvastatin and Ezetimibe: Affects on Family
, 2022 Alopecia areata (AA) is an autoimmune disease that grows in the scalp or in other parts of the body. Alopecia universalis, which is a rare form of alopecia areata, is characterized by a loss of hair that affects the entire body.
Ferhat Ozyurtlu (13995924) +1 more
core +1 more source
A hairless body; An interpretative phenomenological analysis of alopecia universalis.
, 2017 Alopecia areata is not a life-threatening condition, but it is life-altering and it can affect an individual's psychological, emotional and social well-being.
core +6 more sources
Peripheral neuropathy associated with tofacitinib use in alopecia universalis
Journal of Dermatology and Dermatologic Surgery, 2022 Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. Alopecia universalis (AU) is the advanced form of AA characterized by complete scalp and body hair loss.
Raghad Alharthi +4 more
doaj +1 more source
Alopecia Universalis Associated with Cutaneous T Cell Lymphoma
, 2014 Background: Alopecia areata-like hair loss may occur in the context of cutaneous T cell lymphoma (CTCL) and can very rarely evolve to alopecia universalis-like presentation.
Miteva, Mariya +6 more
core +1 more source